MAGEA3 and neoplasm: These results may be attributed to the low level of the CD8+ T-cell response (53) and the possibility that MAGE-A3-mediated lymphocytes may be inactivated and thus fail to kill tumor cells in the postoperative immunosuppressive tumor microenvironment (3).